Literature DB >> 34052332

Delayed skin cancer diagnosis in 2020 due to the COVID-19-related restrictions: data from an institutional registry.

Aimilios Lallas1, Athanassios Kyrgidis2, Sofia-Magdalini Manoli3, Chryssoula Papageorgiou4, Konstantinos Lallas5, Elena Sotiriou5, Efstratios Vakirlis5, Theodoros Sidiropoulos6, Dimitrios Ioannides5, Zoe Apalla7.   

Abstract

Entities:  

Year:  2021        PMID： 34052332     DOI： 10.1016/j.jaad.2021.05.021

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown.

Authors:  Lisa Kostner; Sara Elisa Cerminara; Gustavo Santo Pedro Pamplona; Julia-Tatjana Maul; Reinhard Dummer; Egle Ramelyte; Johanna Mangana; Nikolaus Benjamin Wagner; Antonio Cozzio; Saskia Kreiter; Angelika Kogler; Markus Streit; Anja Wysocki; Alfred Zippelius; Heinz Läubli; Alexander Andreas Navarini; Lara Valeska Maul
Journal:  Cancers (Basel)       Date:  2022-05-10       Impact factor: 6.575

Review 2.  Melanoma Management during the COVID-19 Pandemic Emergency: A Literature Review and Single-Center Experience.

Authors:  Caterina Cariti; Martina Merli; Gianluca Avallone; Marco Rubatto; Elena Marra; Paolo Fava; Virginia Caliendo; Franco Picciotto; Giulio Gualdi; Ignazio Stanganelli; Maria Teresa Fierro; Simone Ribero; Pietro Quaglino
Journal:  Cancers (Basel)       Date:  2021-12-02       Impact factor: 6.639

3.  Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity.

Authors:  R Molinier; A Roger; B Genet; A Blom; C Longvert; L Chaplain; M Fort; P Saiag; E Funck-Brentano
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-11-23       Impact factor: 9.228

4.  Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study.

Authors:  E Koch; F Villanueva; M A Marchetti; Á Abarzúa-Araya; C Cárdenas; J C Castro; F Dominguez; K Droppelmann; N Droppelmann; H Galindo; A León; J Madrid; M Molgó; S Mondaca; P H Montero; P Uribe; M A Villaseca; E Vinés; C Navarrete-Dechent
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-26       Impact factor: 9.228
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.